Skip to main content
. Author manuscript; available in PMC: 2014 Jan 27.
Published in final edited form as: Am J Surg Pathol. 2013 Sep;37(9):1349–1356. doi: 10.1097/PAS.0b013e318290427d

TABLE 4.

Patient Survival by p16 IHC Status

5 y Overall Survival (%) 5 y Disease-free Survival (%) 5 y Disease-specific Survival (%)
p16+* 52 58 80
p16 54 48 73
*

p16+, >50% of tumor cells with nuclear and cytoplasmic staining; p16, no tumor cell staining or <50% of tumor cells with staining.